| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035108461 |
| P356 | DOI | 10.1007/S12031-008-9116-0 |
| P698 | PubMed publication ID | 18592413 |
| P5875 | ResearchGate publication ID | 5259869 |
| P50 | author | Albert Pinhasov | Q42849405 |
| P2093 | author name string | Michal Reichenstein | |
| Moshe Rehavi | |||
| P2860 | cites work | Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). | Q48931112 |
| Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide | Q48939916 | ||
| Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. | Q48943191 | ||
| Central cholinergic effects of tricyclic antidepressants in mouse | Q49056397 | ||
| Neuronal plasticity and survival in mood disorders. | Q52541461 | ||
| Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine | Q56426360 | ||
| Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode | Q59389009 | ||
| Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus | Q61643509 | ||
| Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells | Q69772725 | ||
| Tricyclic antidepressants block cholinergic nicotinic receptors and ATP secretion in bovine chromaffin cells | Q73981247 | ||
| Neurotrophins induce death of hippocampal neurons via the p75 receptor | Q74241776 | ||
| Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication | Q74424004 | ||
| Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1 | Q28202762 | ||
| Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration | Q28216235 | ||
| Is mood chemistry? | Q28237445 | ||
| A neurotrophic model for stress-related mood disorders | Q29616291 | ||
| Neurobiology of depression | Q29619932 | ||
| Neurotrophins and depression | Q33547892 | ||
| Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. | Q33903904 | ||
| A molecular and cellular theory of depression | Q34064955 | ||
| The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily | Q34116167 | ||
| Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain | Q34150827 | ||
| Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants | Q34211475 | ||
| Role of neurotrophic factors in the etiology and treatment of mood disorders | Q34303344 | ||
| Stress, depression, and neuroplasticity: a convergence of mechanisms | Q34686632 | ||
| Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide | Q35892923 | ||
| Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction | Q40537986 | ||
| Pituitary adelylate cyclase-activating peptide is an activator of vasoactive intestinal polypeptide gene transcription in human neuroblastoma cells | Q40864435 | ||
| Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking | Q42464380 | ||
| Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. | Q42473863 | ||
| BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons | Q43575941 | ||
| Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung | Q43774624 | ||
| PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment 106-126. | Q44048930 | ||
| Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects | Q44352569 | ||
| Bi-phasic change in BDNF gene expression following antidepressant drug treatment | Q44426462 | ||
| Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor | Q45157405 | ||
| Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. | Q45202584 | ||
| The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study | Q45252691 | ||
| Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment | Q46688065 | ||
| Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants | Q46940207 | ||
| Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients | Q48188457 | ||
| Aggressive behavior and HPA axis hormones after social isolation in adult rats of two different genetic animal models for depression. | Q48385865 | ||
| Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats | Q48454549 | ||
| Effects of antidepressants on the brain/plasma distribution of corticosterone | Q48565579 | ||
| Decreased serum brain-derived neurotrophic factor levels in major depressed patients | Q48642995 | ||
| Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord | Q48673193 | ||
| P433 | issue | 1-3 | |
| P304 | page(s) | 330–338 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Journal of Molecular Neuroscience | Q15708870 |
| P1476 | title | Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action | |
| P478 | volume | 36 |
| Q30364733 | Bi-directional effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on fear-related behavior and c-Fos expression after fear conditioning in rats. |
| Q35641038 | Blood BDNF level is gender specific in severe depression |
| Q60302041 | Classification of Widely and Rarely Expressed Genes with Recurrent Neural Network |
| Q42601704 | Comparative analysis of the behavioral and biomolecular parameters of four mouse strains. |
| Q38692694 | Effect of social interactions on hippocampal protein expression in animal dominant and submissive model of behavioral disorders |
| Q46117249 | Endocannabinoid receptor deficiency affects maternal care and alters the dam's hippocampal oxytocin receptor and brain-derived neurotrophic factor expression |
| Q28275851 | Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animals |
| Q42491700 | Membrane-tethered AKT kinase regulates basal synaptic transmission and early phase LTP expression by modulation of post-synaptic AMPA receptor level. |
| Q38728328 | Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors |
| Q34280473 | Neuropeptides, growth factors, and cytokines: a cohort of informational molecules whose expression is up-regulated by the stress-associated slow transmitter PACAP in chromaffin cells |
| Q35229429 | PACAP is implicated in the stress axes |
| Q48214160 | Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic Edema |
| Q43087837 | Pituitary adenylate cyclase-activating polypeptide deficiency enhances oxazolone-induced allergic contact dermatitis in mice |
| Q39678162 | Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells. |
| Q38406750 | Seasonality and BDNF polymorphism influences depression outcome in patients with atopic dermatitis and psoriasis |
| Q35904704 | Stimulation of synthesis and release of brain-derived neurotropic factor from intestinal smooth muscle cells by substance P and pituitary adenylate cyclase-activating peptide |
| Q37869518 | VIP-induced neuroprotection of the developing brain |
Search more.